ABCL
AbCellera Biologics Inc.
AbCellera Biologics Inc. (ABCL) has 2 SEC Form 4 filings (2 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 3, 2026.
- Industry:Biotechnology
- CEO:Carl Hansen
- Employees:562
- HQ:Vancouver, BC, CA
- IPO:2020-12-11
Insider Buying
$95K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$1.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Montalbano John S.First filing | Director | Purchase | 20,000 | $95K | May 18 | SEC ↗ |
Related companies
AbCellera Biologics Inc. is in the Healthcare sector.